Leptin and cancer

Journal of Cellular Physiology - Tập 207 Số 1 - Trang 12-22 - 2006
Cecilia Garofalo1, Eva Surmacz2
1Department of Pharmaco-Biology, University of Calabria, Arcavacata di Rende, Cosenza, Italy
2Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania

Tóm tắt

Abstract

The prevalence of obesity has markedly increased over the past two decades, especially in the industrialized countries. While the impact of excess body weight on the development of cardiac disease and diabetes has been well documented, the link between obesity and carcinogenesis is just being recognized. This review will focus on the link between leptin, a cytokine that is elevated in obese individuals, and cancer development. First, we briefly discuss the biological functions of leptin and its signaling pathways. Then, we summarize the effects of leptin on different cancer types in experimental cellular and animal models. Next, we analyze epidemiological data on the relationship between obesity and the presence of cancer or cancer risk in patients. Finally, leptin as a target for cancer treatment and prevention will be discussed. J. Cell. Physiol. 207: 12–22, 2006. © 2005 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1093/ajcn/71.4.901

10.1016/S1043-2760(00)00301-5

10.1038/382250a0

10.1080/gye.16.4.299.306

10.1093/jnci/82.15.1280

10.1006/cyto.2002.1051

10.1074/jbc.M205172200

10.1177/030089160208800213

10.1038/sj.ijo.0801947

10.1096/fj.00-0162

10.1038/29547

10.1007/BF03339728

10.1146/annurev.nutr.20.1.105

10.1038/sj.bjc.6601712

10.1074/jbc.274.30.21416

10.1016/S0960-9822(02)70684-2

10.1210/rp.59.1.305

10.1074/jbc.272.51.32686

10.1074/jbc.M007439200

10.1210/jc.82.9.2904

10.1210/jc.81.9.3419

10.1051/rnd:2002034

10.1093/aje/kwg236

10.1161/01.RES.83.10.1059

10.1016/S0039-128X(01)00138-6

10.1677/jme.0.0260145

10.1210/jcem.86.1.7104

10.1046/j.0953-816x.2001.01628.x

10.1038/sj.ijo.0800561

10.1038/sj.onc.1207751

10.1093/jnci/87.7.517

10.1056/NEJMoa021423

10.1073/pnas.101564798

10.1210/jc.83.6.2149

10.1016/S0015-0282(98)00187-3

10.1074/jbc.M301695200

10.1038/oby.2003.47

10.2337/diabetes.51.7.2105

Chang S, 1998, Inflammatory breast cancer and body mass index, J Clin Oncol, 16, 3731, 10.1200/JCO.1998.16.12.3731

10.1002/1097-0045(200101)46:1<62::AID-PROS1009>3.0.CO;2-V

10.1200/JCO.2002.20.4.1128

10.1210/jc.2004-0297

10.1038/nm0596-585

10.3181/00379727-216-44153B

10.1023/A:1021891825399

10.1207/s15327914nc5002_7

10.1007/s11906-004-0074-9

Cusin I, 1995, The ob gene and insulin. A relationship leading to clues to the understanding of obesity, Diabetes, 44, 1467, 10.2337/diab.44.12.1467

10.1210/jc.82.10.3230

10.1016/S0959-8049(02)00155-7

10.1074/jbc.270.27.15958

10.1038/sj.ijo.0800969

10.1016/S0006-291X(02)00205-X

10.1053/plac.2002.0836

10.1210/jc.82.10.3267

Eng‐Wong J, 2003, Effect of raloxifene on insulin‐like growth factor‐I, insulin‐like growth factor binding protein‐3, and leptin in premenopausal women at high risk for developing breast cancer, Cancer Epidemiol Biomarkers Prev, 12, 1468

Enger SM, 2000, Body size, physical activity, and breast cancer hormone receptor status: Results from two case‐control studies, Cancer Epidemiol Biomarkers Prev, 9, 681

10.1016/S0022-2275(20)32003-4

10.1016/S0029-7844(02)02053-7

10.1073/pnas.94.13.7001

10.1172/JCI9148

10.1016/j.amjsurg.2004.07.031

10.1172/JCI118206

10.1016/j.urology.2004.08.035

10.1001/jama.283.19.2552

10.1158/1078-0432.CCR-04-0203

10.1074/jbc.M205825200

Giacosa A, 1999, Energy intake, overweight, physical exercise and colorectal cancer risk, Eur J Cancer Prev, 8, S53

10.7326/0003-4819-122-5-199503010-00002

10.1007/BF00051301

10.1093/jnci/djg009

10.1055/s-2007-978726

10.1053/gast.2001.29581

10.1016/S0301-2115(02)00359-7

10.1074/jbc.M206775200

10.1038/nm0995-953

10.1385/ENDO:26:1:019

10.1055/s-2007-979878

10.1053/gast.2001.25490

10.1046/j.1467-789X.2003.00108.x

10.1038/nm0996-949b

10.1001/jama.291.23.2847

10.1097/00001648-200205000-00006

10.1210/endo.141.6.7450

10.1073/pnas.94.20.11073

10.1093/jnci/93.10.783

10.1093/jnci/94.22.1704

10.1038/sj.cr.7290038

10.1001/jama.1997.03550170037029

10.1093/oxfordjournals.aje.a010265

10.1097/00075197-200411000-00007

10.1158/1078-0432.CCR-03-0749

10.1006/bbrc.1997.7399

10.1210/jc.84.8.2903

10.1210/jc.82.8.2510

10.1038/sj.pcan.4500421

Kaaks R, 2002, Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review, Cancer Epidemiol Biomarkers Prev, 11, 1531

10.1007/s001250100614

10.1006/bbrc.1996.1059

10.1074/jbc.M204598200

10.1093/molehr/5.8.708

10.1053/gast.2002.35514

10.2337/diab.45.11.1511

10.1210/jc.81.11.4162

10.1182/blood.V93.5.1668.405a15_1668_1676

10.1038/35007508

10.1172/JCI119818

10.1177/002215540205000204

10.1023/A:1015751105039

10.1002/(SICI)1097-0215(19980330)76:1<25::AID-IJC5>3.0.CO;2-#

10.1016/S0303-7207(01)00678-5

10.1016/S0014-5793(02)02889-2

10.1038/sj.bjc.6600782

10.1074/jbc.271.5.2365

10.1093/jn/128.10.1606

Liu Z, 2001, High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin, Int J Oncol, 19, 1009

London SJ, 1989, Prospective study of relative weight, height, and risk of breast cancer, Jama, 262, 2853, 10.1001/jama.1989.03430200097033

10.1210/endo.142.10.8442

10.1385/ENDO:18:2:179

10.1038/nm1195-1155

Magoffin DA, 1999, Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women, Ginekol Pol, 70, 1

10.1016/S0960-0760(97)00082-4

10.1002/(SICI)1097-0215(19990209)80:4<523::AID-IJC7>3.0.CO;2-C

10.1081/CEH-200031948

10.1016/S0378-5122(00)00121-3

10.1016/0014-5793(95)01472-1

10.1001/jama.286.8.921

10.1097/00001648-199601000-00008

10.1152/ajpendo.00003.2004

10.1016/0959-8049(94)90254-2

10.1677/jme.0.0220173

10.1016/S0090-4295(01)01175-X

10.1046/j.1365-2141.1998.00843.x

10.1023/A:1015770423167

10.1006/bbrc.1999.0843

Oda A, 2001, Leptin stimulates rat aortic smooth muscle cell proliferation and migration, Kobe J Med Sci, 47, 141

10.1016/S0167-4889(02)00276-8

10.1210/endo.142.11.8494

10.1074/jbc.M304984200

10.1093/jjco/hye097

10.1038/emm.2001.17

10.1023/A:1008903727238

10.1159/000063081

10.1530/eje.0.1380086

10.1002/pros.20121

Potter JD, 1995, Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there?, Cancer Epidemiol Biomarkers Prev, 4, 319

10.1210/en.139.10.4264

10.1023/A:1012267619561

Rose DP, 2002, Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review), Int J Oncol, 21, 1285

10.1210/jc.81.9.3424

10.1001/jama.288.3.321

10.1074/jbc.M312999200

10.1097/01.ju.0000055903.18400.25

10.1038/377527a0

10.1055/s-2004-814490

10.1210/endo.138.10.5573

10.1126/science.281.5383.1683

10.1093/jnci/90.22.1710

Simons JP, 1997, Plasma concentration of total leptin and human lung‐cancer‐associated cachexia, Clin Sci (Lond), 93, 273, 10.1042/cs0930273

10.1172/JCI118551

10.1210/jcem.83.5.4952

10.1016/0021-9150(89)90029-4

10.1097/01.AOG.0000154151.14516.f7

10.1016/S0022-4804(03)00166-5

10.1016/j.jss.2004.01.017

10.1210/jc.86.3.1341

Stattin P, 2003, Plasma leptin is not associated with prostate cancer risk, Cancer Epidemiol Biomarkers Prev, 12, 474

Stattin P, 2003, Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden, Oncol Rep, 10, 2015

10.1023/B:BREA.0000036782.11945.d7

10.1378/chest.122.6_suppl.326S

10.1207/S15327914NC4501_1

10.1023/A:1015729615148

10.1016/S0898-6568(02)00006-2

10.1074/jbc.272.10.6093

10.1054/bjoc.2001.1894

10.1136/gut.51.2.191

Tessitore L, 2000, Leptin expression in colorectal and breast cancer patients, Int J Mol Med, 5, 421

10.1053/meta.2000.9519

10.1016/S0014-2999(98)00884-X

10.3109/02841869209088902

10.1038/31474

10.1530/eje.0.1430293

10.1074/jbc.272.7.4065

10.1210/me.2004-0027

10.1158/0008-5472.CAN-04-0655

10.1016/j.ygyno.2003.11.043

10.1016/S0014-5793(03)00440-X

10.1038/372425a0

10.1016/S0303-7207(99)00194-X